SF 4485 Minnesota Senate · 2019-2020 Regular Session

Resolution memorializing the President and Congress to direct the United States Food and Drug Administration to approve off-label use of certain medications to combat COVID-19

Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2020
Committee Review
Floor Vote
Governor
Introduced Apr 16, 2020 Last action May 11, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Apr 16, 2020
Committee
Referred to Health and Human Services Finance and Policy
upper
Apr 16, 2020
Introduced
Introduction and first reading
upper
0 primary · 4 co-sponsors

Sponsors

No sponsor information available.